Details
-
Type:
Task
-
Status: Closed (View Workflow)
-
Priority:
Major
-
Resolution: Done
-
Affects Version/s: None
-
Fix Version/s: None
-
Labels:None
-
Story Points:0.5
-
Sprint:Spring 1 2022 Jan 3 - Jan 14, Spring 3 2022 Jan 31 - Feb 11, Spring 4 2022 Feb 14 - Feb 25
Description
The number of comparisons and questions we can answer about splicing and methylation seem almost infinite, and to publish our work, we need to focus on a small set of these questions.
For this task, articulate questions about our data related to splicing that we could potentially answer in the Frontiers paper. Explain why the questions matter, and describe how the answer to the question can be interpreted.
Attachments
Issue Links
Activity
Field | Original Value | New Value |
---|---|---|
Epic Link | IGBF-3039 [ 21553 ] |
Description |
The number of comparisons and questions we can answer about splicing and methylation seem almost infinite, and to publish our work, we need to focus on a small set of these questions.
For this task, articulate a small set of questions about our data related to splicing that we could potentially answer in the Frontiers paper. |
The number of comparisons and questions we can answer about splicing and methylation seem almost infinite, and to publish our work, we need to focus on a small set of these questions.
For this task, articulate questions about our data related to splicing that we could potentially answer in the Frontiers paper. Explain why the questions matter, and describe how the answer to the question can be interpreted. |
Sprint | Spring 1 2022 Jan 3 - Jan 14 [ 136 ] | Spring 1 2022 Jan 3 - Jan 14, Spring 2 2022 Jan 18 - Jan 28 [ 136, 137 ] |
Rank | Ranked higher |
Sprint | Spring 1 2022 Jan 3 - Jan 14, Spring 2 2022 Jan 18 - Jan 28 [ 136, 137 ] | Spring 1 2022 Jan 3 - Jan 14 [ 136 ] |
Rank | Ranked higher |
Sprint | Spring 1 2022 Jan 3 - Jan 14 [ 136 ] | Spring 1 2022 Jan 3 - Jan 14, Spring 3 2022 Jan 31 - Feb 11 [ 136, 138 ] |
Comment | [ test ] |
Assignee | Nowlan Freese [ nfreese ] |
Status | To-Do [ 10305 ] | In Progress [ 3 ] |
Sprint | Spring 1 2022 Jan 3 - Jan 14, Spring 3 2022 Jan 31 - Feb 11 [ 136, 138 ] | Spring 1 2022 Jan 3 - Jan 14, Spring 3 2022 Jan 31 - Feb 11, Spring 4 2022 Feb 14 - Feb 25 [ 136, 138, 139 ] |
Rank | Ranked higher |
Sprint | Spring 1 2022 Jan 3 - Jan 14, Spring 3 2022 Jan 31 - Feb 11, Spring 4 2022 Feb 14 - Feb 25 [ 136, 138, 139 ] | Spring 1 2022 Jan 3 - Jan 14, Spring 3 2022 Jan 31 - Feb 11 [ 136, 138 ] |
Sprint | Spring 1 2022 Jan 3 - Jan 14, Spring 3 2022 Jan 31 - Feb 11 [ 136, 138 ] | Spring 1 2022 Jan 3 - Jan 14, Spring 3 2022 Jan 31 - Feb 11, Spring 4 2022 Feb 14 - Feb 25 [ 136, 138, 139 ] |
Status | In Progress [ 3 ] | To-Do [ 10305 ] |
Status | To-Do [ 10305 ] | In Progress [ 3 ] |
Status | In Progress [ 3 ] | To-Do [ 10305 ] |
Status | To-Do [ 10305 ] | In Progress [ 3 ] |
Status | In Progress [ 3 ] | Needs 1st Level Review [ 10005 ] |
Status | Needs 1st Level Review [ 10005 ] | First Level Review in Progress [ 10301 ] |
Status | First Level Review in Progress [ 10301 ] | Ready for Pull Request [ 10304 ] |
Status | Ready for Pull Request [ 10304 ] | Pull Request Submitted [ 10101 ] |
Status | Pull Request Submitted [ 10101 ] | Reviewing Pull Request [ 10303 ] |
Status | Reviewing Pull Request [ 10303 ] | Merged Needs Testing [ 10002 ] |
Status | Merged Needs Testing [ 10002 ] | Post-merge Testing In Progress [ 10003 ] |
Resolution | Done [ 10000 ] | |
Status | Post-merge Testing In Progress [ 10003 ] | Closed [ 6 ] |